Maria Doladé

Maria Doladé

Auto-generated profile, based on publicly available information

Maria Doladé

Hospital Germans Trias i Pujol, Badalona, Spain

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in The Lancet
Verified
Journal Article
Closed access
MPMarina Pollán
Marina Pollán
BPBeatriz Pérez-Gómez
Beatriz Pérez-Gómez
RPRoberto Pastor-Barriuso
Roberto Pastor-Barriuso
JOJesús Oteo
Jesús Oteo
Mayte Perez-OlmedaMayte Perez-Olmeda
Mayte Perez-Olmeda
AVAntonia Vázquez de la Villa
Antonia Vázquez de la Villa

28 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJaume Barallat
Jaume Barallat
GFGema Fernández-Rivas
Gema Fernández-Rivas
BQBibiana Quirant
Bibiana Quirant
VGVictoria González
Victoria González
MDMaria Doladé
Maria Doladé
Ignacio BlancoIgnacio Blanco
Ignacio Blanco
Background: The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) around the world has caused a global pandemic, infecting millions of individuals, with an unprecedented impact in health care systems worldwide. Healthcare workers are one of the risk groups that need to be well protected, due to their strategic role in patient management, presently and in prevention of healthcare needs for future outbreaks. Here, we present the results of the first SARS-CoV-2 seroprevalence study in the Northern Metropolitan Area of Barcelona, Spain. Methods: IgG SARS-CoV-2 antibodies were analyzed in serum samples from 7563 healthcare workers of the Northern Metropolitan Area of Barcelona. Samples were collected after the first pandemic wave (from May 4th to May 22nd, 2020) and were analyzed by automated chemiluminescence assays. All samples were tested for IgG anti-S1/S2. Participant samples with negative or equivocal results but with analytical signals above the limit of detection and/or previously confirmed COVID-19 diagnosis were also tested for IgG anti-Nucleocapsid. Results: A total of 779 of 7563 (10.3%) healthcare workers were positive for anti-SARS-CoV-2 IgG (specific for either S1/S2 or N antigens). No significant differences were observed between those working at primary care or at the reference hospital. Interestingly, among 341 participants with a confirmed COVID-19 diagnosis, 36 (10.55%) tested negative for SARS-CoV-2 IgG (both S1/S2 and recombinant N antigen). Conclusion: Seroprevalence of anti-SARS-CoV-2 IgG in the healthcare workers of the North Metropolitan Area of Barcelona was higher than in the general population in the same geographical area. Safety measures have to be stressed in order to protect these essential workers from future pandemic waves.

4 September 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CECarmen Expósito
Carmen Expósito
GPGuillem Pera
Guillem Pera
LRLluís Rodríguez
Lluís Rodríguez
IPIngrid Cecibel Arteaga Pillasagua
Ingrid Cecibel Arteaga Pillasagua
AMAlba Martínez-Escudé
Alba Martínez-Escudé
LCLlorenç Caballeria
Llorenç Caballeria
The aim of this study was to determine the prevalence of early chronic kidney disease (EKD) (stages 1 and 2) and the factors associated. This was a populational study including individuals from 18–75 years randomly selected from 18 Primary Healthcare centers in the area of Barcelonès Nord and Maresme (Catalunya, Spain). Variables: anamnesis, physical examination, blood pressure, and analysis. EKD was defined with by a glomerular filtration rate (GFR) ≥60 mL/min/1.73 m2 and albumin/creatinine ratio (ACR) ≥17 mg/g in men and ≥25 mg/g in women confirmed with two determinations. 2871 individuals: 43% men, mean age 55 years (19–75), 32.2% obese, 50.5% abdominal obesity, 21.1% hypertensive, and 10.6% diabetic. Prevalence of EKD: With one determination 157 individuals (5.5%), 110 men (9%) and 47 women (2.8%); with two determinations 109 individuals (3.8%), 85 men (7%), and 24 women (1.5%). Factors independently associated with the multivariate logistic regression model: Man (OR 3.35), blood pressure ≥ 135/85 mmHg (OR 2.29), BMI ≥ 30 kg/m2 (OR 2.48), glycemia ≥ 100 mg/dL (OR 1.73), smoker (OR 1.67) and age (OR 1.04). The prevalence varies if the diagnosis is established based on one or two analytical determinations, overestimated if only one determination is made and depends on the value chosen to define urine albumin excretion.

1 October 2010 in Transplantation Proceedings
Verified
Journal Article
Closed access
ASA. Sánchez-Escuredo
A. Sánchez-Escuredo
MPM.C. Pastor
M.C. Pastor
BBB. Bayés
B. Bayés
CMC. Morales-Indiano
C. Morales-Indiano
MTM. Troya
M. Troya
RLR. Lauzurica
R. Lauzurica

6 February 2013 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
MAMontserrat Arzoz-Fabregas
Montserrat Arzoz-Fabregas
LILuis Ibarz-Servio
Luis Ibarz-Servio
SESílvia Edo-Izquierdo
Sílvia Edo-Izquierdo
MDMaría Doladé-Botías
María Doladé-Botías
JFJordi Fernández-Castro
Jordi Fernández-Castro
JRJosep Roca-Antonio
Josep Roca-Antonio

3 August 2020 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Open access
PDF file
LJLaura Jimenez-Anon
Laura Jimenez-Anon
JBJaume Barallat
Jaume Barallat
DRDiana Regidor
Diana Regidor
EUEulalia Urgell
Eulalia Urgell
MDMaria Dolade
Maria Dolade
MGMaría Luisa Granada
María Luisa Granada
Article Assessment of intraindividual agreement in prolactin results after post-polyethylene glycol precipitation test for the estimation of macroprolactin. Should the precipitation procedure be repeated in the same patient? was published on January 1, 2021 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 59, issue 1).